A recent study by Khodoun et al. [93] conducted on FA-induced mice demonstrated that IL-25, IL-33, and TSLP inhibition through specific monoclonal antibodies (mAbs) strongly inhibited FA development. The gene discussed is IL33; the disease is Friedreich ataxia.